NEO: NeoGenomics Inc. Stocks News on April 19, 2025

NEO

Argus Research

3 days ago

NEO: Rating decreased to a SELL

NEO

MT Newswires

5 days ago

BofA Securities Adjusts Price Target on NeoGenomics to $12 From $16, Maintains Neutral Rating

NEO

Argus Research

10 days ago

NEO: Lowering target price to $9.00

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

NEO

Business Wire

11 days ago

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

NEO

MT Newswires

12 days ago

NeoGenomics Closes Pathline Acquisition

NeoGenomics Completes Acquisition of Pathline

NEO

Business Wire

12 days ago

NeoGenomics Completes Acquisition of Pathline

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

NEO

StockStory

16 days ago

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

NEO

Argus Research

17 days ago

NEO: What does Argus have to say about NEO?

NEO

MT Newswires

18 days ago

NeoGenomics Appoints Tony Zook Chief Executive

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

NEO

Business Wire

18 days ago

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack

NEO

StockStory

23 days ago

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack

Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses

NEO

StockStory

24 days ago

Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses

3 Reasons to Sell NEO and 1 Stock to Buy Instead

NEO

StockStory

a month ago

3 Reasons to Sell NEO and 1 Stock to Buy Instead

NEO

MT Newswires

a month ago

NeoGenomics Names Warren Stone President, COO

NeoGenomics Appoints Warren Stone as President & Chief Operating Officer

NEO

Business Wire

a month ago

NeoGenomics Appoints Warren Stone as President & Chief Operating Officer

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)

NEO

StockStory

a month ago

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)

NEO

StockStory

a month ago

3 Small-Cap Stocks in Hot Water

NEO

MT Newswires

a month ago

NeoGenomics Acquires Pathline

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

NEO

Business Wire

a month ago

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

NEO

Argus Research

a month ago

NEO: Lowering target price to $10.00

NEO

StockStory

2 months ago

3 Healthcare Stocks Skating on Thin Ice

NEO

Argus Research

2 months ago

NEO: Lowering target price to $11.00

NeoGenomics to Participate in Upcoming Investor Conferences

NEO

Business Wire

2 months ago

NeoGenomics to Participate in Upcoming Investor Conferences

NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations

NEO

Simply Wall St.

2 months ago

NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations

NEO

GuruFocus.com

2 months ago

NeoGenomics Inc (NEO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

NEO

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Neogenomics Inc Earnings Call

NEO

Argus Research

2 months ago

NEO: Lowering target price to $13.00

Why NeoGenomics (NEO) Shares Are Trading Lower Today

NEO

StockStory

2 months ago

Why NeoGenomics (NEO) Shares Are Trading Lower Today

NeoGenomics (NEO) Tops Q4 Earnings Estimates

NEO

Zacks

2 months ago

NeoGenomics (NEO) Tops Q4 Earnings Estimates

NEO

MT Newswires

2 months ago

NeoGenomics Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued -- Shares Drop Pre-Bell

NEO

Associated Press Finance

2 months ago

NeoGenomics: Q4 Earnings Snapshot

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets

NEO

StockStory

2 months ago

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

NEO

Business Wire

2 months ago

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect

NEO

StockStory

2 months ago

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect

NEO

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Adaptive Biotechnologies Corp Earnings Call

NEO

Argus Research

2 months ago

NEO: Lowering target price to $15.00

NEO

MT Newswires

3 months ago

Pacific Biosciences of California Appoints NeoGenomics CEO to Board of Directors

PacBio Announces Appointment of Chris Smith to Board of Directors

NEO

GlobeNewswire

3 months ago

PacBio Announces Appointment of Chris Smith to Board of Directors

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

NEO

Business Wire

3 months ago

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

NEO

Argus Research

3 months ago

NEO: Raising target price to $16.00

Strong week for NeoGenomics (NASDAQ:NEO) shareholders doesn't alleviate pain of five-year loss

NEO

Simply Wall St.

3 months ago

Strong week for NeoGenomics (NASDAQ:NEO) shareholders doesn't alleviate pain of five-year loss

NEO

Argus Research

3 months ago

NEO: Raising target price to $15.00

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

NEO

Investor's Business Daily

3 months ago

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

NEO

MT Newswires

3 months ago

NeoGenomics Provides 2025 Revenue Outlook

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

NEO

Business Wire

3 months ago

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?

NEO

Zacks

3 months ago

NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?

NEO

Argus Research

3 months ago

NEO: Lowering target price to $14.00

NEO

MT Newswires

3 months ago

Adaptive Biotechnologies, NeoGenomics to Support Minimal Residual Disease Monitoring Options for Blood Cancer Patients

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

NEO

GlobeNewswire

3 months ago

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

NEO

MT Newswires

3 months ago

Benchmark Downgrades NeoGenomics to Hold From Buy

NEO

MT Newswires

3 months ago

NeoGenomics Appoints Tony Zook as CEO

NeoGenomics Announces Chief Executive Officer Succession

NEO

Business Wire

3 months ago

NeoGenomics Announces Chief Executive Officer Succession

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

NEO

Business Wire

3 months ago

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

NeoGenomics (NEO) Upgraded to Buy: Here's Why

NEO

Zacks

4 months ago

NeoGenomics (NEO) Upgraded to Buy: Here's Why

NEO

Argus Research

4 months ago

NEO: Lowering target price to $17.00

NEO

Argus Research

4 months ago

NEO: Rating increased to a HOLD

NEO

MT Newswires

4 months ago

Natera Expands Lawsuit Against NeoGenomics to Include Additional Patent

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

NEO

Business Wire

4 months ago

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

NEO

Argus Research

4 months ago

NEO: Raising target price to $17.00

NEO

MT Newswires

4 months ago

Jefferies Initiates NeoGenomics at Buy With $22 Price Target

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

NEO

Business Wire

4 months ago

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

NEO

Argus Research

5 months ago

NEO: Raising target price to $16.00

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

NEO

Business Wire

5 months ago

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Felicia Williams Joins NeoGenomics Board of Directors

NEO

Business Wire

5 months ago

Felicia Williams Joins NeoGenomics Board of Directors

NEO

Argus Research

5 months ago

NEO: Raising target price to $17.00

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

NEO

Business Wire

5 months ago

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

NeoGenomics (NEO) Upgraded to Strong Buy: Here's What You Should Know

NEO

Zacks

5 months ago

NeoGenomics (NEO) Upgraded to Strong Buy: Here's What You Should Know

NeoGenomics Third Quarter 2024 Earnings: EPS Beats Expectations

NEO

Simply Wall St.

5 months ago

NeoGenomics Third Quarter 2024 Earnings: EPS Beats Expectations

NEO

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Neogenomics Inc Earnings Call

NEO

GuruFocus.com

5 months ago

NeoGenomics Inc (NEO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

NEO

Argus Research

5 months ago

NEO: Raising target price to $16.00

NeoGenomics (NEO) Reports Q3 Earnings: What Key Metrics Have to Say

NEO

Zacks

5 months ago

NeoGenomics (NEO) Reports Q3 Earnings: What Key Metrics Have to Say

NEO

MT Newswires

5 months ago

NeoGenomics' Q3 Adjusted Earnings, Revenue Rise

NEO

Associated Press Finance

5 months ago

NeoGenomics: Q3 Earnings Snapshot

NeoGenomics Reports Third Quarter 2024 Results

NEO

Business Wire

5 months ago

NeoGenomics Reports Third Quarter 2024 Results

Wall Street Analysts Believe NeoGenomics (NEO) Could Rally 51.29%: Here's is How to Trade

NEO

Zacks

5 months ago

Wall Street Analysts Believe NeoGenomics (NEO) Could Rally 51.29%: Here's is How to Trade

NeoGenomics gains conditional approval for solid tumour assays in New York

NEO

Medical Device Network

6 months ago

NeoGenomics gains conditional approval for solid tumour assays in New York

NEO

MT Newswires

6 months ago

NeoGenomics Gets Conditional Approval for Cancer Tests in New York

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

NEO

Business Wire

6 months ago

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

NEO

Business Wire

6 months ago

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

NeoGenomics (NEO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

NEO

Zacks

6 months ago

NeoGenomics (NEO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

NEO

Business Wire

6 months ago

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

NEO

MT Newswires

7 months ago

Update: Natera Says Court Orders Permanent Injunction Against NeoGenomics' RaDaR Assay

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

NEO

Business Wire

7 months ago

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

NEO

MT Newswires

7 months ago

Natera Says Court Orders Permanent Injunction Against NeoGenomics' RaDaR Assay

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

NEO

Business Wire

7 months ago

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

NEO

Business Wire

8 months ago

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

NEO

Argus Research

8 months ago

NEO: What does Argus have to say about NEO?

NEO

Argus Research

8 months ago

NEO: What does Argus have to say about NEO?

Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q2 Earnings

NEO

Zacks

9 months ago

Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q2 Earnings

NEO

MT Newswires

9 months ago

NeoGenomics Swings to Q2 Adjusted Profit, Revenue Increases; Raises 2024 Revenue Outlook

NEO

Associated Press Finance

9 months ago

NeoGenomics: Q2 Earnings Snapshot

NeoGenomics Reports Second Quarter 2024 Results

NEO

Business Wire

9 months ago

NeoGenomics Reports Second Quarter 2024 Results

NEO

Argus Research

9 months ago

NEO: Lowering target price to $12.00

NeoGenomics (NASDAQ:NEO) shareholders have endured a 68% loss from investing in the stock three years ago

NEO

Simply Wall St.

9 months ago

NeoGenomics (NASDAQ:NEO) shareholders have endured a 68% loss from investing in the stock three years ago

Is NeoGenomics, Inc. (NEO) the Most Profitable Stock of the Last 20 Years?

NEO

Insider Monkey

9 months ago

Is NeoGenomics, Inc. (NEO) the Most Profitable Stock of the Last 20 Years?

NEO

Argus Research

9 months ago

NEO: Raising target price to $13.00

NEO

Argus Research

9 months ago

NEO: What does Argus have to say about NEO?

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024

NEO

Business Wire

9 months ago

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024

NEO

Argus Research

10 months ago

Latest NeoGenomics Inc. (NEO) News on April 19, 2025

Share on Social Networks: